← Back to Dashboard

Epclusa

NS5B polymerase inhibitor + NS5A inhibitor

Constituent drugs (2)

Sofosbuvir

Could not render structureView on PubChem
No structure available on PubChemSearch PubChem
PubChem CID 45375808

Velpatasvir

Could not render structureView on PubChem
3D not available

Chemical Identifiers

ClinicalTrials.govPubMed

Clinical Development by Virus1

Hepatitis C virus
HCV
Target: Viral NS5B + NS5A
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (kegg.jp) Approval ref (pmda.go.jp) PMDA approved 2019/1/8fixed-dose combination of Sofosbuvir, Velpatasvir.